The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer

The glucose metabolism reprogramming is a hallmark of cancer. The oncoprotein hepatitis B X-interacting protein (HBXIP) functions in the development of breast cancer. In this study, we supposed that HBXIP might be involved in the glucose metabolism reprogramming in breast cancer. We showed that HBXI...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fabao, Zhang, Weiying, You, Xiaona, Liu, Yunxia, Li, Yinghui, Wang, Zhen, Wang, Yue, Zhang, Xiaodong, Ye, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694983/
https://www.ncbi.nlm.nih.gov/pubmed/26309161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694983/
https://www.ncbi.nlm.nih.gov/pubmed/26309161

Ejemplares similares